PharmaBoardroom

Thailand Medical Tourism Snapshot

Thailand was the world's fourth-largest medical tourism destination in 2017, with a market value of around USD 600 million. Made with Visme…

Thailand Healthcare Snapshot 2019

Thailand's healthcare expenditure is projected to rise from USD 25.3 billion in 2016 to 47.9 billion by 2026, a ten-year CAGR of 6.6%. Made…

GE Healthcare Egypt: Reimagining Care Provision

Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how his affiliate has grown to be the partner of choice for the Egyptian…

Shing-Mou Lee – Founder and President, EMO Biomedicine,…

Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory…

Specialising to Succeed in the Spanish Women’s Health Market

In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be increasingly focused and specialised to…

Catalonia: At the Forefront of Spanish Healthcare

The North-Eastern region of Catalonia is one of Spain’s most prosperous and has been allocating increasingly large amounts of its budget towards…

Tung-Mao Su – Chairman, Taiwan Pharmaceutical…

Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’…

HB Chen – President, TaiwanBio Therapeutics

HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique…

Juan Santiago – President, Colegio de Químicos de Puerto…

Lcdo. Juan Santiago - EIT, President of the Colegio de Químicos Puerto Rico, explains the far-reaching role of chemists in Puerto Rico’s industry,…

Cell & Gene Therapies: Transforming our Vision of Healthcare…

Emanuele Ostuni, head of cell & gene therapy for Novartis Oncology in Europe, outlines how stakeholders across the biopharmaceutical value chain…

5 Ways to Achieve a Sustainable US Health System

In the face of rising costs in American healthcare, Carla Smith outlines five ways in which the US can improve the financial sustainability of its…

Bayer: Betting Big on Cell & Gene Therapy

Bayer's latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell…

Tagged with HE